Clinical Trials Logo

Clinical Trial Summary

A prospective multicentre study which aims to examine the relationship between intratumour heterogeneity (ITH) and pathological response to neoadjuvant chemotherapy in patients with histological confirmation of triple-negative breast cancer (TNBC) who are eligible for neoadjuvant chemotherapy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03077776
Study type Interventional
Source UNICANCER
Contact
Status Active, not recruiting
Phase N/A
Start date April 14, 2017
Completion date May 2026

See also
  Status Clinical Trial Phase
Withdrawn NCT02685306 - A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer Phase 2